These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 14447015)

  • 1. Drug resistance in out-patients treated with sodium PAS and isoniazid cachets.
    SIMPSON JM
    Tubercle; 1959 Dec; 40():453-6. PubMed ID: 14447015
    [No Abstract]   [Full Text] [Related]  

  • 2. An evaluation of chemotherapy in pulmonary tuberculosis. High doses of isoniazid and PAS versus daily streptomycin with high doses of isoniazid and PAS.
    BERTE SJ; BOWEN CD
    Am Rev Respir Dis; 1960 Mar; 81():407-11. PubMed ID: 13799949
    [No Abstract]   [Full Text] [Related]  

  • 3. Bacterial resistance to streptomycin, PAS and isoniazid in untreated patients with symptomatic pulmonary tuberculosis in Ashanti.
    BELL WJ; BROWN PP
    Tubercle; 1960 Aug; 41():247-52. PubMed ID: 13798526
    [No Abstract]   [Full Text] [Related]  

  • 4. The prevalence of bacterial resistance to isoniazid and to PAS in patients with acute pulmonary tuberculosis presenting for treatment in East Africa.
    PEPYS J; MITCHISON DA; KINSLEY BJ
    Tubercle; 1960 Feb; 41():32-6. PubMed ID: 14431677
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of isoniazid alone with isoniazid--PAS in the original chemotherapy of noncavitary pulmonary tuberculosis. Results from the Veterans Administration-Armed Forces co-operative study on the chemotherapy of tuberculosis.
    PHILLIPS S
    Am Rev Respir Dis; 1959 Nov; 80():641-7. PubMed ID: 14432637
    [No Abstract]   [Full Text] [Related]  

  • 6. Usefulness of a combined isoniazid, para-aminosalicylic acid and pyridoxine preparation.
    MANDEL W
    Am Pract Dig Treat; 1959 Oct; 10():1737-9. PubMed ID: 14420557
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of working conditions on chemotherapy of pulmonary tuberculosis].
    YASHIRO A
    Nihon Eiseigaku Zasshi; 1961 Jun; 16():105-10. PubMed ID: 13787252
    [No Abstract]   [Full Text] [Related]  

  • 8. [Modern chemotherapy of pulmonary tuberculosis (a summary of WHO & NTA statements)].
    LEE HK
    Hanguk Uiyak; 1962; 5():11-4. PubMed ID: 14463496
    [No Abstract]   [Full Text] [Related]  

  • 9. [Is resistance break-through possible after INH and PAS long-term therapy in pulmonary tuberculosis by the use of INHA-PAS?].
    DEBERTSHAUSER E
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1961; 124():450-5. PubMed ID: 13884647
    [No Abstract]   [Full Text] [Related]  

  • 10. A concurrent comparison of isoniazid plus PAS with three regimens of isoniazid alone in the domiciliary treatment of pulmonary tuberculosis in South India.
    Tuberculosis Chemotherapy Centre
    Bull World Health Organ; 1960; 23(4-5):535-85. PubMed ID: 14447270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [On ambulant therapy of pulmonary tuberculosis in the aged].
    SUGIMOTO H
    Chiryo; 1962 Aug; 44():1525-31. PubMed ID: 13918208
    [No Abstract]   [Full Text] [Related]  

  • 12. The treatment of chronic cavitating pulmonary tuberculosis by long-term chemotherapy.
    BLAKE DH
    Tubercle; 1961 Dec; 42():438-43. PubMed ID: 13869754
    [No Abstract]   [Full Text] [Related]  

  • 13. [Action of the PAS salt of isoniazid in pulmonary tuberculosis].
    KOURILSKY R; KOURILSKY S; THUILLIER Y
    Sem Hop; 1956 Jun; 32(34):1948-55. PubMed ID: 13351700
    [No Abstract]   [Full Text] [Related]  

  • 14. [Combined treatment of pulmonary tuberculosis with DSM pantothenate, INH and PAS in continuous infusion].
    HERZOG H; STAUB H; REBER H; PFALTZ R; von BERTRAB ; BURRI HP; CREUX G; von DESCHWANDEN ; SCHMID R; VOUTE C
    Schweiz Z Tuberc Pneumonol; 1960; 17():303-27. PubMed ID: 13713883
    [No Abstract]   [Full Text] [Related]  

  • 15. A short-term clinical trial with a combination of INH and PAS in the treatment of tuberculosis in infants and children.
    VYAS KJ
    J Indian Med Assoc; 1961 Feb; 36():149-52. PubMed ID: 13782301
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of benemid to enhance blood-levels of sodium para-aminosalicylate (PAS).
    MCLEOD JA; TURNBULL FW; CROFTON JW
    Tubercle; 1953 Jun; 34(6):152-5. PubMed ID: 13077745
    [No Abstract]   [Full Text] [Related]  

  • 17. Benemid and sodium PAS.
    SIMMONDS FA; HESS EV
    Tubercle; 1952 May; 33(5):138-42. PubMed ID: 14942897
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of pulmonary tuberculosis in its various clinical forms with streptomycin, para-aminosalicylic acid (PAS), thiosemicarbazone (TB1) and isoniazid].
    CARBAJO JJ
    Rev Clin Esp; 1955 Dec; 59(5):316-9. PubMed ID: 13310921
    [No Abstract]   [Full Text] [Related]  

  • 19. Isoniazid and para-aminosalicylic acid toxicity in 513 cases: a study including high doses of INH and gastrointestinal intolerance to PAS.
    BERTE SJ; DEWLETT HJ
    Dis Chest; 1959 Aug; 36(2):146-51. PubMed ID: 13672072
    [No Abstract]   [Full Text] [Related]  

  • 20. [PAS concentration in the pulmonary tuberculosis lesion. Part I. Punctual movement of PAS-Na concentration intravenously injected. I].
    HASHIMOTO T
    Kekkaku; 1959 Dec; 34():870-5. PubMed ID: 13851958
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.